Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

An augmented cognitive behavioural therapy for treating post-stroke depression: description of a treatment protocol.

Kootker JA, Rasquin SM, Smits P, Geurts AC, van Heugten CM, Fasotti L.

Clin Rehabil. 2014 Dec 1. pii: 0269215514559987. [Epub ahead of print]

PMID:
25452633
2.

Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection.

Andrade C, Bolwig TG.

J ECT. 2014 Jun;30(2):160-4. doi: 10.1097/YCT.0000000000000133. Review.

PMID:
24800688
3.

The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.

Rizzo LB, Costa LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, McIntyre RS, Bauer ME, Brietzke E.

Neurosci Biobehav Rev. 2014 May;42:157-69. doi: 10.1016/j.neubiorev.2014.02.004. Epub 2014 Feb 15. Review.

PMID:
24548785
4.

Inflamed moods: a review of the interactions between inflammation and mood disorders.

Rosenblat JD, Cha DS, Mansur RB, McIntyre RS.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:23-34. doi: 10.1016/j.pnpbp.2014.01.013. Epub 2014 Jan 25. Review.

PMID:
24468642
5.

Transcranial direct current stimulation for refractory auditory hallucinations in schizophrenia.

Andrade C.

J Clin Psychiatry. 2013 Nov;74(11):e1054-8. doi: 10.4088/JCP.13f08826.

PMID:
24330906
6.

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Mereu M, Bonci A, Newman AH, Tanda G.

Psychopharmacology (Berl). 2013 Oct;229(3):415-34. doi: 10.1007/s00213-013-3232-4. Epub 2013 Aug 10. Review.

7.

Psychiatry beyond the current paradigm.

Bracken P, Thomas P, Timimi S, Asen E, Behr G, Beuster C, Bhunnoo S, Browne I, Chhina N, Double D, Downer S, Evans C, Fernando S, Garland MR, Hopkins W, Huws R, Johnson B, Martindale B, Middleton H, Moldavsky D, Moncrieff J, Mullins S, Nelki J, Pizzo M, Rodger J, Smyth M, Summerfield D, Wallace J, Yeomans D.

Br J Psychiatry. 2012 Dec;201(6):430-4. doi: 10.1192/bjp.bp.112.109447.

8.

Oxotremorine treatment restores hippocampal neurogenesis and ameliorates depression-like behaviour in chronically stressed rats.

Veena J, Srikumar BN, Mahati K, Raju TR, Shankaranarayana Rao BS.

Psychopharmacology (Berl). 2011 Sep;217(2):239-53. doi: 10.1007/s00213-011-2279-3. Epub 2011 Apr 16.

PMID:
21494789
9.

Geriatric psychopharmacology: evolution of a discipline.

Meyers BS, Jeste DV.

J Clin Psychiatry. 2010 Nov;71(11):1416-24. doi: 10.4088/JCP.10r06485gry.

PMID:
21114947
10.

Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Bhagya V, Srikumar BN, Raju TR, Rao BS.

Psychopharmacology (Berl). 2011 Mar;214(2):477-94. doi: 10.1007/s00213-010-2054-x. Epub 2010 Nov 4.

PMID:
21052984
11.

Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males.

Kennedy DO, Veasey R, Watson A, Dodd F, Jones E, Maggini S, Haskell CF.

Psychopharmacology (Berl). 2010 Jul;211(1):55-68. doi: 10.1007/s00213-010-1870-3. Epub 2010 May 8.

12.

Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.

Baker AL, Hides L, Lubman DI.

J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry. Review.

PMID:
20331929
13.

The new chemistry of mind: a hypothesis.

Szára S.

Neuropsychopharmacol Hung. 2008 Jun;10(3):141-50. Review.

14.

Understanding the placebo effect. Part 2: underlying psychological & neurobiological processes.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Jun;46(6):15-8. Review.

PMID:
18595454
15.

Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.

McIntyre RS, Soczynska JK, Lewis GF, MacQueen GM, Konarski JZ, Kennedy SH.

Expert Opin Pharmacother. 2006 Jul;7(10):1305-21.

PMID:
16805717
16.

Cannabis and neurodevelopment: implications for psychiatric disorders.

Sundram S.

Hum Psychopharmacol. 2006 Jun;21(4):245-54. Review.

PMID:
16783814
17.

Neuroethics.

Glannon W.

Bioethics. 2006 Feb;20(1):37-52.

PMID:
16680906
18.

Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S.

Psychopharmacology (Berl). 2005 Dec;183(2):190-200. Epub 2005 Nov 9.

PMID:
16220338
19.

The effects of lithium on cognition: an updated review.

Pachet AK, Wisniewski AM.

Psychopharmacology (Berl). 2003 Nov;170(3):225-34. Epub 2003 Sep 19. Review.

PMID:
14504681
20.

High but not low ECS stimulus intensity augments apomorphine-stimulated dopamine postsynaptic receptor functioning in rats.

Andrade C, Srinivasamurthy GM, Vishwasenani A, Prakash GS, Srihari BS, Chandra JS.

J ECT. 2002 Jun;18(2):80-3.

PMID:
12195135
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk